| Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia S Kapur, R Zipursky, C Jones, G Remington, S Houle American journal of psychiatry 157 (4), 514-520, 2000 | 1434 | 2000 |
| A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy S Kapur, R Zipursky, C Jones, CS Shammi, G Remington, P Seeman Archives of general psychiatry 57 (6), 553-559, 2000 | 544 | 2000 |
| 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation S Kapur, RB Zipursky, G Remington, C Jones, J DaSilva, AA Wilson, ... American Journal of Psychiatry 155 (7), 921-928, 1998 | 505 | 1998 |
| prefrontal cortex in S Kapur, FIM Craik, C Jones, GM Brown, S Houle, E Tulving Neuroreport 6, 1880-1884, 1995 | 428 | 1995 |
| High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. S Kapur, G Remington, C Jones, A Wilson, J DaSilva, S Houle, R Zipursky The American journal of psychiatry 153 (7), 948-950, 1996 | 326 | 1996 |
| Significant dissociation of brain and plasma kinetics with antipsychotics J Tauscher, C Jones, G Remington, RB Zipursky, S Kapur Molecular psychiatry 7 (3), 317-321, 2002 | 188 | 2002 |
| Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats MLG Wadenberg, S Kapur, A Soliman, C Jones, F Vaccarino Psychopharmacology 150, 422-429, 2000 | 187 | 2000 |
| The relationship between D2 receptor occupancy and plasma levels on low dose oral haloperidol: a PET study S Kapur, R Zipursky, P Roy, C Jones, G Remington, K Reed, S Houle Psychopharmacology 131, 148-152, 1997 | 149 | 1997 |
| Serotonin 5-HT2 Receptors in Schizophrenia: A PET Study Using [18F]Setoperone in Neuroleptic-Naive Patients and Normal Subjects R Lewis, S Kapur, C Jones, J DaSilva, GM Brown, AA Wilson, S Houle, ... American Journal of Psychiatry 156 (1), 72-78, 1999 | 137 | 1999 |
| Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade S Tauscher-Wisniewski, S Kapur, J Tauscher, C Jones, ZJ Daskalakis, ... Journal of Clinical Psychiatry 63 (11), 992-997, 2002 | 117 | 2002 |
| PET Evidence That Loxapine Is an Equipotent Blocker of 5-HT2 and D2 Receptors: Implications for the Therapeutics of Schizophrenia S Kapur, R Zipursky, G Remington, C Jones, G McKay, S Houle American Journal of Psychiatry 154 (11), 1525-1529, 1997 | 115 | 1997 |
| Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy S Kapur, R Cho, C Jones, G McKay, RB Zipursky Biological psychiatry 45 (9), 1217-1220, 1999 | 73 | 1999 |
| Cyproheptadine: a potent in vivo serotonin antagonist. S Kapur, RB Zipursky, C Jones, AA Wilson, JD DaSilva, S Houle The American journal of psychiatry 154 (6), 884-884, 1997 | 68 | 1997 |
| The D2 receptor occupancy profile of loxapine determined using PET S Kapur, RB Zipursky, C Jones, GJ Remington, AA Wilson, J DaSilva, ... Neuropsychopharmacology 15 (6), 562-566, 1996 | 67 | 1996 |
| Comparison of height and weight in homosexual versus nonhomosexual male gender dysphorics R Blanchard, R Dickey, CL Jones Archives of Sexual Behavior 24, 543-554, 1995 | 53 | 1995 |
| Does evaluation of in vitro microfilarial motility reflect the resistance status of Dirofilaria immitis isolates to macrocyclic lactones? MJ Maclean, MD Savadelis, R Coates, MT Dzimianski, C Jones, ... Parasites & vectors 10, 17-23, 2017 | 38 | 2017 |
| Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging S KAPUR, C JONES, J DaSILVA, A WILSON, S HOULE Nuclear medicine communications 18 (5), 395-399, 1997 | 36 | 1997 |
| N-allyl-5-fluoropropylepidepride (fallypride): radiation dosimetry, quantification of striatal and extrastriatal dopamine receptors in man RM Kessler, NS Mason, C Jones, MS Ansari, RG Manning, RR Price Neuroimage 11, S32, 2000 | 21 | 2000 |
| 371. Transient d2 dopamine receptor occupancy in low EPS-incidence drugs: PET evidence C Jones, S Kapur, G Remington, RB Zipursky Biological Psychiatry 47 (8), S112, 2000 | 19 | 2000 |
| Community screening outcomes for diabetes, hypertension, and cholesterol: Nashville REACH 2010 project K Patel, C Larson, M Hargreaves, D Schlundt, H Wang, C Jones, K Beard The Journal of ambulatory care management 33 (2), 155-162, 2010 | 18 | 2010 |
Shitij KapurKing's College LondonVerified email at kcl.ac.uk
